Literature DB >> 367592

Malignant pleural effusions.

M A Friedman, E Slater.   

Abstract

Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy. Aggressive management including chest tube drainage, with or without instillation of inflammation-inducing drugs, and radiotherapy or surgery in selected cases is indicated for palliative treatment and probably for increased survival. In formulating a treatment plan, attention should be given to a variety of factors including pathogenic forces in the formation of malignant pleural effusion, tissue type of the metastatic malignancy, general clinical status of the patient, the presence of pleural loculations and adhesions, and the exclusion of other non-malignant causes of pleural effusion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 367592     DOI: 10.1016/s0305-7372(78)80006-1

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  4 in total

1.  Management of malignant pleural effusion.

Authors:  P T Reid; R M Rudd
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

2.  Volumetric compression develops noise-driven single-cell heterogeneity.

Authors:  Xing Zhao; Jiliang Hu; Yiwei Li; Ming Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

3.  Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin.

Authors:  S Koldsland; J L Svennevig; G Lehne; E Johnson
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

Review 4.  Diagnosis and treatment of malignant pleural effusion.

Authors:  F H Hausheer; J W Yarbro
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.